Collectively, these results suggest that CTLA-4 overexpression inhibits CD4+ T-cell activation and their accumulation in the para-aortic LNs and aneurysmal lesions of angiotensin II-infused hypercholesterolemic mice, leading to suppression of pathogenic immunoinflammatory responses and AAA development. The gene discussed is CTLA4; the disease is triple-A syndrome.